Home: PCU
3|2003: Paul F Schellhammer, MD: Select publications
Select publications
Articles discussed by Dr Schellhammer
Bailar JC III, Byar DP. Estrogen treatment for cancer of the prostate:
Early results with 3 doses of
diethylstilbestrol and placebo. Cancer 1970;26:257–261. Abstract
Byar DP. Proceedings of the Veterans Administration Cooperative Urological
Research Group’s
studies of cancer of the prostate. Cancer 1973;32:1126–1130. Abstract
Byar DP, Corle DK. Hormone therapy for prostate cancer: Results of
the Veterans Administration
Cooperative Urological Research Group studies. NCI Monogr 1988;7:165–170.
Abstract
Medical Research Council Prostate Working Party Investigators Group.
Immediate versus deferred
treatment for advanced prostatic cancer: Initial results of the Medical Research
Council trial. Br J Urol 1997;79:235–246. Abstract
Salvage therapy after failure of definitive local therapy
Chawla AK et al. Salvage radiotherapy after radical prostatectomy for
prostate adenocarcinoma:
Analysis of efficacy and prognostic factors. Urology 2002;59(5):726-31. Abstract
Djavan B et al. PSA progression following radical prostatectomy and
radiation therapy: New
standards in the new millennium. Eur Urol 2003;43(1):12-27. Abstract
Duchesne GM et al. What to do for prostate cancer patients with a rising
PSA? — A
survey of
Australian practice. Int J Radiat Oncol Biol Phys 2003;55(4):986-91. Abstract
Katz MS et al. Predictors of biochemical outcome with salvage conformal
radiotherapy after radical
prostatectomy for prostate cancer. J Clin Oncol 2003;21(3):483-9. Abstract
Johnstone PAet al. Initiation of salvage therapy for prostate cancer. Prostate
Cancer Prostatic Dis
2002;5(2):136-43. Abstract
Mosbacher MR et al. Postprostatectomy salvage radiation therapy
for prostate cancer: Impact of
pathological and biochemical variables and prostate fossa biopsy. Cancer
J 2002;8(3):242-6. Abstract
Pollack A et al. Prostate cancer DNA ploidy and response to salvage
hormone therapy after
radiotherapy with or without short-term total androgen blockade: An
analysis of RTOG 8610. J Clin Oncol 2003;21(7):1238-48. Abstract
Scherr D et al. National Comprehensive Cancer Network guidelines for
the management of prostate
cancer. Urology 2003;61(2 Suppl 1):14-24. Abstract
Shipley WU et al. Effect of a short course of neoadjuvant hormonal
therapy on the response to
subsequent androgen suppression in prostate cancer patients with
relapse after radiotherapy: A
secondary analysis of the randomized protocol RTOG 86-10. Int J
Radiat Oncol Biol Phys
2002;54(5):1302-10. Abstract
|
